# A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01

> **NCT05570422** · PHASE1 · RECRUITING · sponsor: **Kortuc, Inc.** · enrollment: 70 (estimated)

## Conditions studied

- Cervical Cancer

## Interventions

- **DRUG:** KRC-01
- **RADIATION:** External Beam Radiation Therapy
- **DRUG:** cisplatin
- **RADIATION:** brachytherapy

## Key facts

- **NCT ID:** NCT05570422
- **Lead sponsor:** Kortuc, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2027-01-30
- **Final completion:** 2027-03-30
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05570422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05570422, "A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05570422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*